Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.

Sponsor
Bezmialem Vakif University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04367272
Collaborator
(none)
163
2
13.5

Study Details

Study Description

Brief Summary

The effects of single-team simultaneous bilateral total knee arthroplasty on peri- and postoperative complications are clear. The investigators hypothesized that second knee at risk during single-team simultaneous bilateral total knee arthroplasty and have more early postoperative complication rates than the first knee. Therefore, this prospective study compared minor and major local complications for 90 days postoperatively between the first and second during knee single-team simultaneous bilateral total knee arthroplasty.

Condition or Disease Intervention/Treatment Phase
  • Procedure: First Arthroplasty
  • Procedure: Second Arthroplasty
N/A

Detailed Description

The investigators would like to compare operation related technical complications and periprosthetic joint infection rate between the first and second knee.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
163 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.
Anticipated Study Start Date :
May 15, 2020
Anticipated Primary Completion Date :
May 15, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: First Knee

The first knee is the knee where the surgery will begin to be applied.

Procedure: First Arthroplasty
First Knee

Experimental: Second Knee

The second knee is the knee where the surgeon will apply secondly.

Procedure: Second Arthroplasty
Second Knee

Outcome Measures

Primary Outcome Measures

  1. Local complications [90 days]

    Local operation related complications rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary bilateral knee osteoarthritis with refractory to conservative treatment

  • Patients who accept participation in the research and the randomization

Exclusion Criteria:
  • no history of malignancy

  • less than 75 years old

  • severe cardiac insufficiency and morbid obesity

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Bezmialem Vakif University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Orkhan Aliyev, Residents Doctor in Orthopedics Department, Principal Investigator, Bezmialem Vakif University
ClinicalTrials.gov Identifier:
NCT04367272
Other Study ID Numbers:
  • 27.04.2020-02
First Posted:
Apr 29, 2020
Last Update Posted:
Apr 30, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 30, 2020